Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cell & gene therapy

Research Field Cell & gene therapy

Cell Therapy Virtuoso

| Catherine Bollard

Catherine Bollard, President of the International Society for Cellular Therapy

Research Field Cardiovascular

Biomaterials at the Heart of Regeneration

| Matteo Santin, Stefan Jockenhövel, and Garry Duffy

How to mend a broken heart? The latest biomaterials for cardiac regenerative medicine.

Research Field Cell & gene therapy

Lessons I’ve Learned, With Michael West

| Michael West

Visionary gerontologist and BioTime CEO Michael West shares his lessons learned

Research Field Cell & gene therapy

DNA on the Cutting Room Floor

| Charlotte Barker

CRISPR is the new kid on the block, but do ZFNs and TALENs still have a place?

Research Field Cancer

Rac Attack

| William Aryitey

Rac1 helps to remodel breast tissue - could it also clear cancer cells?

Research Field Metabolism & Diabetes

An Islet Odyssey

| Charlotte Barker

Cell therapies for Type 1 diabetes aim to make hypoglycemic attacks a thing of the past

Research Field Cell & gene therapy

Buried Treasure

| William Aryitey

Previously thought to be "junk", long noncoding RNAs may play a central role in cancer

Tools & Techniques Cancer

Video: Inside The Translational Scientist

Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.

Tools & Techniques Cancer

Immune U-Turn

“Extraordinary” results from a T-cell therapy trial offer hope to leukemia patients – and to researchers toiling in unfashionable fields.

Tools & Techniques Cell & gene therapy

Stemming the Flow

A gene therapy approach for hemophilia-causing Factor VII deficiency shows early promise

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts